4DMedical expands U.S. presence

4DMedical (ASX:4DX), a leader in respiratory imaging technology, has signed a commercial contract with the University of Chicago Medicine. This partnership allows clinicians to use 4DMedical's imaging products, including the CT LVASTM, to treat complex lung diseases. The agreement is part of 4DMedical's strategy to grow within the U.S. healthcare system.

4DMedical's strategic U.S. expansion

4DMedical has entered into a significant partnership with the University of Chicago Medicine, furthering its U.S. expansion strategy. This collaboration allows the use of their advanced imaging solutions in treating lung diseases. The company also expanded its contract with UCSD Health, reflecting the increasing demand for its technology. 4DMedical focuses on enhancing precision in lung disease diagnosis and management. Through strategic partnerships and expansions, 4DMedical aims to establish key reference sites in the U.S., bolstering its presence in the healthcare market while continuing to innovate in respiratory imaging technology.

Executive insights on new partnership

This partnership with the University of Chicago Medicine is a significant milestone for 4DMedical as we continue to expand our presence in the U.S. market. The demand for our technology demonstrates the value it brings to clinicians and patients.